Network-Based Microbial Compositions for Gut Microbiome Restoration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current probiotics are limited in their ability to adequately replace missing natural microflora and correct dysbioses in the gastrointestinal tract, failing to effectively prevent or treat conditions such as Clostridium difficile Associated Diarrhea, Type 2 Diabetes, Obesity, and Irritable Bowel Disease.
Innovation Solution
A therapeutic bacterial composition comprising a network ecology of specific isolated bacteria, capable of forming functional pathways, is administered to restore or enhance microbiota functions, including the use of bacteria from clades like Clostridium glycyrrhizinilyticum, Faecalibacterium prausnitzii, and Alistipes putredinis, to induce the formation of short chain fatty acids and modulate the gut microbiome.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional probiotics are used, then a narrow group of genera and species can be administered, but they fail to adequately replace missing natural microflora and correct dysbioses
Solution Approach 1:
The patent segments the complex gut microbiome into specific functional modules by isolating and characterizing distinct bacterial clades (e.g., Clostridium glycyrrhizinilyticum, Faecalibacterium prausnitzii, Alistipes putredinis) that perform specific functions. This allows the complex system to be managed through modular, functionally-defined components rather than treating the entire microbiome as a uniform entity.
Solution Approach 2:
The patent creates composite bacterial preparations that combine multiple isolated bacteria from different clades into a single therapeutic composition. These composite formulations integrate the functional benefits of multiple species (e.g., combining butyrate-producing bacteria with anti-inflammatory clades) to achieve synergistic effects that single-species probiotics cannot accomplish.
2Reliability
If a broad spectrum of bacteria is administered to restore microbiota functions, then treatment effectiveness improves, but manufacturing and standardization become more difficult
Solution Approach 1:
The patent establishes specific parameters for bacterial isolation, including defined criteria for clade identification, minimum abundance thresholds, and functional characterization markers. By standardizing these parameters across different preparations, the patent enables consistent manufacturing and quality control while maintaining the broad spectrum necessary for therapeutic effectiveness.
Solution Approach 2:
The patent replaces traditional mechanical culture-based probiotic production with a molecular biology approach using metagenomic sequencing and bioinformatics to identify and characterize bacterial clades. This substitution allows for more precise control over bacterial composition and function, facilitating standardization while maintaining therapeutic breadth.
3Productivity
If multiple bacterial clades are combined to form network ecology, then functional pathways are enhanced, but the system complexity increases
Solution Approach 1:
The patent merges multiple bacterial clades into integrated network ecologies where different species perform complementary functions. For example, butyrate-producing clades are combined with anti-inflammatory clades and carbohydrate-active enzymes in a single preparation, creating synergistic metabolic pathways that produce short chain fatty acids and other beneficial metabolites more efficiently than individual species could alone.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The therapeutic bacterial composition effectively treats and prevents various gastrointestinal disorders by restoring the gut microbiome, reducing pathogen colonization, and improving metabolic profiles, leading to enhanced immune function and overall health.
Implementation Method 1
induce the formation of short chain fatty acids
Data Source
AI summary
Provided are therapeutic compositions containing combinations of bacteria, for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract of a mammalian subject, and methods for use thereof.